Tae Won Jang

The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea

Hee Joung Kim, Seung Hun Jang, Jeong‐Seon Ryu et al. · Lung Cancer · 2015 · 59 citations · Full text

Medicine, Biostatistics, Oncology +15

Isoniazid Population Pharmacokinetics and Dose Recommendation for Korean Patients With Tuberculosis Based on Target Attainment Analysis

Yong‐Soon Cho, Tae Won Jang, Hyo‐Jung Kim et al. · The Journal of Clinical Pharmacology · 2021 · 26 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis

Byung Woo Yoon, Jae‐Hoon Kim, Seung Hyeun Lee et al. · Translational Oncology · 2019 · 17 citations · Full text

Medicine, Oncology, Pharmacology +11

Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea

Taeyun Kim, Tae Won Jang, Chang‐Min Choi et al. · Cancer Medicine · 2021 · 17 citations · Full text

Medicine, Oncology, Pharmacology +14

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer

Jang Ho Lee, Eun Young Kim, Cheol‐Kyu Park et al. · Cancer Research and Treatment · 2022 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16